Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

Sponsor
Istituto Ortopedico Rizzoli
Study ID
NCT06243588
Status
Recruiting
Apply to this trial

Conditions

  • Ewing Sarcoma

Eligibility Criteria

Sex
ALL
Age
2 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • clinical records review — OTHER
    review the medical records, radiological imaging, and histological data of these patients

Study Details

assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma. Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.

Key Dates

First listed
Feb 6, 2024
Start date
Jan 25, 2024
Status verified
Mar 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Patients
    patients treated at Rizzoli Institute from 1991 to 2021.

Primary Outcome Measure

Correlation [ Time Frame: At baseline (Day 0) ]

Central Contacts

Related Studies